Global Neuroprotection Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Neuroprotection

• 1.1 Definition of Neuroprotection
• 1.2 Neuroprotection Segment by Type
  • 1.2.1 Global Neuroprotection Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Free Radical Trapping Agents (Antioxidants)
  • 1.2.3 Glutamate Antagonists (Anti-Excitotoxic Agents)
  • 1.2.4 Apoptosis Inhibitors
  • 1.2.5 Anti-inflammatory Agents
  • 1.2.6 Neurotrophic Factors (NTFs)
  • 1.2.7 Metal Ion Chelators
  • 1.2.8 Stimulants
  • 1.2.9 Others
• 1.3 Neuroprotection Segment by Applications
  • 1.3.1 Global Neuroprotection Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Prevention
  • 1.3.3 Treatment
• 1.4 Global Neuroprotection Overall Market
  • 1.4.1 Global Neuroprotection Revenue (2014-2025)
  • 1.4.2 Global Neuroprotection Production (2014-2025)
  • 1.4.3 North America Neuroprotection Status and Prospect (2014-2025)
  • 1.4.4 Europe Neuroprotection Status and Prospect (2014-2025)
  • 1.4.5 China Neuroprotection Status and Prospect (2014-2025)
  • 1.4.6 Japan Neuroprotection Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Neuroprotection Status and Prospect (2014-2025)
  • 1.4.8 India Neuroprotection Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Neuroprotection
• 2.3 Manufacturing Process Analysis of Neuroprotection
• 2.4 Industry Chain Structure of Neuroprotection

3 Development and Manufacturing Plants Analysis of Neuroprotection

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Neuroprotection Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Neuroprotection
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Neuroprotection Production and Capacity Analysis
• 4.2 Neuroprotection Revenue Analysis
• 4.3 Neuroprotection Price Analysis
• 4.4 Market Concentration Degree

5 Neuroprotection Regional Market Analysis

• 5.1 Neuroprotection Production by Regions
  • 5.1.1 Global Neuroprotection Production by Regions
  • 5.1.2 Global Neuroprotection Revenue by Regions
• 5.2 Neuroprotection Consumption by Regions
• 5.3 North America Neuroprotection Market Analysis
  • 5.3.1 North America Neuroprotection Production
  • 5.3.2 North America Neuroprotection Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Neuroprotection Import and Export
• 5.4 Europe Neuroprotection Market Analysis
  • 5.4.1 Europe Neuroprotection Production
  • 5.4.2 Europe Neuroprotection Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Neuroprotection Import and Export
• 5.5 China Neuroprotection Market Analysis
  • 5.5.1 China Neuroprotection Production
  • 5.5.2 China Neuroprotection Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Neuroprotection Import and Export
• 5.6 Japan Neuroprotection Market Analysis
  • 5.6.1 Japan Neuroprotection Production
  • 5.6.2 Japan Neuroprotection Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Neuroprotection Import and Export
• 5.7 Southeast Asia Neuroprotection Market Analysis
  • 5.7.1 Southeast Asia Neuroprotection Production
  • 5.7.2 Southeast Asia Neuroprotection Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Neuroprotection Import and Export
• 5.8 India Neuroprotection Market Analysis
  • 5.8.1 India Neuroprotection Production
  • 5.8.2 India Neuroprotection Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Neuroprotection Import and Export

6 Neuroprotection Segment Market Analysis (by Type)

• 6.1 Global Neuroprotection Production by Type
• 6.2 Global Neuroprotection Revenue by Type
• 6.3 Neuroprotection Price by Type

7 Neuroprotection Segment Market Analysis (by Application)

• 7.1 Global Neuroprotection Consumption by Application
• 7.2 Global Neuroprotection Consumption Market Share by Application (2014-2019)

8 Neuroprotection Major Manufacturers Analysis

• 8.1 Daiichi Sankyo Company
  • 8.1.1 Daiichi Sankyo Company Neuroprotection Production Sites and Area Served
  • 8.1.2 Daiichi Sankyo Company Product Introduction, Application and Specification
  • 8.1.3 Daiichi Sankyo Company Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Eli Lilly and Company
  • 8.2.1 Eli Lilly and Company Neuroprotection Production Sites and Area Served
  • 8.2.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.2.3 Eli Lilly and Company Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Allergan
  • 8.3.1 Allergan Neuroprotection Production Sites and Area Served
  • 8.3.2 Allergan Product Introduction, Application and Specification
  • 8.3.3 Allergan Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Dr. Reddy’s Laboratories
  • 8.4.1 Dr. Reddy’s Laboratories Neuroprotection Production Sites and Area Served
  • 8.4.2 Dr. Reddy’s Laboratories Product Introduction, Application and Specification
  • 8.4.3 Dr. Reddy’s Laboratories Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Teva Pharmaceutical
  • 8.5.1 Teva Pharmaceutical Neuroprotection Production Sites and Area Served
  • 8.5.2 Teva Pharmaceutical Product Introduction, Application and Specification
  • 8.5.3 Teva Pharmaceutical Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Novartis
  • 8.6.1 Novartis Neuroprotection Production Sites and Area Served
  • 8.6.2 Novartis Product Introduction, Application and Specification
  • 8.6.3 Novartis Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 AstraZeneca
  • 8.7.1 AstraZeneca Neuroprotection Production Sites and Area Served
  • 8.7.2 AstraZeneca Product Introduction, Application and Specification
  • 8.7.3 AstraZeneca Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Astrocyte Pharmaceuticals
  • 8.8.1 Astrocyte Pharmaceuticals Neuroprotection Production Sites and Area Served
  • 8.8.2 Astrocyte Pharmaceuticals Product Introduction, Application and Specification
  • 8.8.3 Astrocyte Pharmaceuticals Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 F. Hoffmann-La Roche
  • 8.9.1 F. Hoffmann-La Roche Neuroprotection Production Sites and Area Served
  • 8.9.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.9.3 F. Hoffmann-La Roche Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Biogen
  • 8.10.1 Biogen Neuroprotection Production Sites and Area Served
  • 8.10.2 Biogen Product Introduction, Application and Specification
  • 8.10.3 Biogen Neuroprotection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Neuroprotection Market

• 9.1 Global Neuroprotection Market Trend Analysis
  • 9.1.1 Global Neuroprotection Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Neuroprotection Regional Market Trend
  • 9.2.1 North America Neuroprotection Forecast 2019-2025
  • 9.2.2 Europe Neuroprotection Forecast 2019-2025
  • 9.2.3 China Neuroprotection Forecast 2019-2025
  • 9.2.4 Japan Neuroprotection Forecast 2019-2025
  • 9.2.5 Southeast Asia Neuroprotection Forecast 2019-2025
  • 9.2.6 India Neuroprotection Forecast 2019-2025
• 9.3 Neuroprotection Market Trend (Product Type)
• 9.4 Neuroprotection Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Neuroprotection Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List